Question 1

What is Vifor Pharma (Switzerland) known for?

Accepted Answer

In research, Vifor Pharma (Switzerland) stands highest in Health Sciences (#5,440 of 16,688 worldwide) and Medicine (#6,200 of 14,558 worldwide), over all time.

Question 2

How does Vifor Pharma (Switzerland) rank in research?

Accepted Answer

Vifor Pharma (Switzerland) ranks #19,826 of 22,385 institutions worldwide on research quality in 2022-now (#19,093 all time), and #157 of 186 in Switzerland.

Question 3

Who are the top researchers at Vifor Pharma (Switzerland)?

Accepted Answer

Ranked on the quality score, Bernard Roubert, Vania Manolova and Franz Dürrenberger lead among researchers whose main affiliation is Vifor Pharma (Switzerland).

Question 4

What are the most cited papers from Vifor Pharma (Switzerland)?

Accepted Answer

The most cited paper from Vifor Pharma (Switzerland) is "Ferric Carboxymaltose in Patients with Heart Failure and Iron Deficiency" (Stefan D. Anker, Josep Comín Colet, Gerasimos S Filippatos et al., 2009), with 2,090 citations. Next come "Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiency" (1,245) and "Ferric carboxymaltose for iron deficiency at discharge after acute heart failure: a multicentre, double-blind, randomised, controlled trial" (797).

Question 5

Which research topics does Vifor Pharma (Switzerland) publish most on?

Accepted Answer

By volume in 2022-now: Iron Metabolism and Disorders, Potassium and Related Disorders, Dermatology and Skin Diseases and Renal Diseases and Glomerulopathies.

Question 6

Which keywords describe research at Vifor Pharma (Switzerland)?

Accepted Answer

By fractional works in 2022-now, weighted toward what it does more of than the world: Heart Failure, Chronic Kidney Disease, Inflammation, Diagnosis, Cardiovascular Disease, Anemia, Iron Deficiency and Erythropoiesis.

Question 7

Which fields of science does Vifor Pharma (Switzerland) work in?

Accepted Answer

In 2022-now, 68% of research at Vifor Pharma (Switzerland) is in Health Sciences, 15% in Life Sciences. Its largest fields are Medicine (63%), Agricultural and Biological Sciences (6%), Engineering (4%). It does 2.7× the world's share of Health Sciences.

Question 8

Is Vifor Pharma (Switzerland)'s research output growing?

Accepted Answer

Output in 2022-2025 was 28% higher than in 2018-2021.